Covid-19 Impact on Respiratory Infectious Disease Diagnostics Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Respiratory Infectious Disease Diagnostics, including the following market information:
Major competitors identified in this market include Abbott Laboratories, Thermo Fisher Scientific., Abbott, Koninklijke Philips, Cardinal Health, COSMED, Smiths Group, NIHON KOHDEN CORPORATION, Becton, Dickinson, F.Hoffmann, etc.
Based on the Region:
- Global Respiratory Infectious Disease Diagnostics Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Respiratory Infectious Disease Diagnostics Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Respiratory Infectious Disease Diagnostics Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Respiratory Infectious Disease Diagnostics Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Major competitors identified in this market include Abbott Laboratories, Thermo Fisher Scientific., Abbott, Koninklijke Philips, Cardinal Health, COSMED, Smiths Group, NIHON KOHDEN CORPORATION, Becton, Dickinson, F.Hoffmann, etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Mechanical Tests
- Imaging Tests
- In Vitro Diagnostics (IVD) Tests
- Hospitals
- Clinical Laboratories
- Physician Offices
- Others
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Respiratory Infectious Disease Diagnostics Industry
1.7 COVID-19 Impact: Respiratory Infectious Disease Diagnostics Market Trends
2 GLOBAL RESPIRATORY INFECTIOUS DISEASE DIAGNOSTICS QUARTERLY MARKET SIZE ANALYSIS
2.1 Respiratory Infectious Disease Diagnostics Business Impact Assessment - COVID-19
2.1.1 Global Respiratory Infectious Disease Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Respiratory Infectious Disease Diagnostics Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Respiratory Infectious Disease Diagnostics Quarterly Market Size, 2019 VS 2020
3.2 By Players, Respiratory Infectious Disease Diagnostics Headquarters and Area Served
3.3 Date of Key Players Enter into Respiratory Infectious Disease Diagnostics Market
3.4 Key Players Respiratory Infectious Disease Diagnostics Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON RESPIRATORY INFECTIOUS DISEASE DIAGNOSTICS SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Mechanical Tests
1.4.2 Imaging Tests
1.4.3 In Vitro Diagnostics (IVD) Tests
4.2 By Type, Global Respiratory Infectious Disease Diagnostics Market Size, 2019-2021
5 IMPACT OF COVID-19 ON RESPIRATORY INFECTIOUS DISEASE DIAGNOSTICS SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Hospitals
5.5.2 Clinical Laboratories
5.5.3 Physician Offices
5.5.4 Others
5.2 By Application, Global Respiratory Infectious Disease Diagnostics Market Size, 2019-2021
5.2.1 By Application, Global Respiratory Infectious Disease Diagnostics Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Business Overview
7.1.2 Abbott Laboratories Respiratory Infectious Disease Diagnostics Quarterly Revenue, 2020
7.1.3 Abbott Laboratories Respiratory Infectious Disease Diagnostics Product Introduction
7.1.4 Abbott Laboratories Response to COVID-19 and Related Developments
7.2 Thermo Fisher Scientific.
7.2.1 Thermo Fisher Scientific. Business Overview
7.2.2 Thermo Fisher Scientific. Respiratory Infectious Disease Diagnostics Quarterly Revenue, 2020
7.2.3 Thermo Fisher Scientific. Respiratory Infectious Disease Diagnostics Product Introduction
7.2.4 Thermo Fisher Scientific. Response to COVID-19 and Related Developments
7.3 Abbott
7.3.1 Abbott Business Overview
7.3.2 Abbott Respiratory Infectious Disease Diagnostics Quarterly Revenue, 2020
7.3.3 Abbott Respiratory Infectious Disease Diagnostics Product Introduction
7.3.4 Abbott Response to COVID-19 and Related Developments
7.4 Koninklijke Philips
7.4.1 Koninklijke Philips Business Overview
7.4.2 Koninklijke Philips Respiratory Infectious Disease Diagnostics Quarterly Revenue, 2020
7.4.3 Koninklijke Philips Respiratory Infectious Disease Diagnostics Product Introduction
7.4.4 Koninklijke Philips Response to COVID-19 and Related Developments
7.5 Cardinal Health
7.5.1 Cardinal Health Business Overview
7.5.2 Cardinal Health Respiratory Infectious Disease Diagnostics Quarterly Revenue, 2020
7.5.3 Cardinal Health Respiratory Infectious Disease Diagnostics Product Introduction
7.5.4 Cardinal Health Response to COVID-19 and Related Developments
7.6 COSMED
7.6.1 COSMED Business Overview
7.6.2 COSMED Respiratory Infectious Disease Diagnostics Quarterly Revenue, 2020
7.6.3 COSMED Respiratory Infectious Disease Diagnostics Product Introduction
7.6.4 COSMED Response to COVID-19 and Related Developments
7.7 Smiths Group
7.7.1 Smiths Group Business Overview
7.7.2 Smiths Group Respiratory Infectious Disease Diagnostics Quarterly Revenue, 2020
7.7.3 Smiths Group Respiratory Infectious Disease Diagnostics Product Introduction
7.7.4 Smiths Group Response to COVID-19 and Related Developments
7.8 NIHON KOHDEN CORPORATION
7.8.1 NIHON KOHDEN CORPORATION Business Overview
7.8.2 NIHON KOHDEN CORPORATION Respiratory Infectious Disease Diagnostics Quarterly Revenue, 2020
7.8.3 NIHON KOHDEN CORPORATION Respiratory Infectious Disease Diagnostics Product Introduction
7.8.4 NIHON KOHDEN CORPORATION Response to COVID-19 and Related Developments
7.9 Becton
7.9.1 Becton Business Overview
7.9.2 Becton Respiratory Infectious Disease Diagnostics Quarterly Revenue, 2020
7.9.3 Becton Respiratory Infectious Disease Diagnostics Product Introduction
7.9.4 Becton Response to COVID-19 and Related Developments
7.10 Dickinson
7.10.1 Dickinson Business Overview
7.10.2 Dickinson Respiratory Infectious Disease Diagnostics Quarterly Revenue, 2020
7.10.3 Dickinson Respiratory Infectious Disease Diagnostics Product Introduction
7.10.4 Dickinson Response to COVID-19 and Related Developments
7.11 F.Hoffmann
7.11.1 F.Hoffmann Business Overview
7.11.2 F.Hoffmann Respiratory Infectious Disease Diagnostics Quarterly Revenue, 2020
7.11.3 F.Hoffmann Respiratory Infectious Disease Diagnostics Product Introduction
7.11.4 F.Hoffmann Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Respiratory Infectious Disease Diagnostics Industry
1.7 COVID-19 Impact: Respiratory Infectious Disease Diagnostics Market Trends
2 GLOBAL RESPIRATORY INFECTIOUS DISEASE DIAGNOSTICS QUARTERLY MARKET SIZE ANALYSIS
2.1 Respiratory Infectious Disease Diagnostics Business Impact Assessment - COVID-19
2.1.1 Global Respiratory Infectious Disease Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Respiratory Infectious Disease Diagnostics Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Respiratory Infectious Disease Diagnostics Quarterly Market Size, 2019 VS 2020
3.2 By Players, Respiratory Infectious Disease Diagnostics Headquarters and Area Served
3.3 Date of Key Players Enter into Respiratory Infectious Disease Diagnostics Market
3.4 Key Players Respiratory Infectious Disease Diagnostics Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON RESPIRATORY INFECTIOUS DISEASE DIAGNOSTICS SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Mechanical Tests
1.4.2 Imaging Tests
1.4.3 In Vitro Diagnostics (IVD) Tests
4.2 By Type, Global Respiratory Infectious Disease Diagnostics Market Size, 2019-2021
5 IMPACT OF COVID-19 ON RESPIRATORY INFECTIOUS DISEASE DIAGNOSTICS SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Hospitals
5.5.2 Clinical Laboratories
5.5.3 Physician Offices
5.5.4 Others
5.2 By Application, Global Respiratory Infectious Disease Diagnostics Market Size, 2019-2021
5.2.1 By Application, Global Respiratory Infectious Disease Diagnostics Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Business Overview
7.1.2 Abbott Laboratories Respiratory Infectious Disease Diagnostics Quarterly Revenue, 2020
7.1.3 Abbott Laboratories Respiratory Infectious Disease Diagnostics Product Introduction
7.1.4 Abbott Laboratories Response to COVID-19 and Related Developments
7.2 Thermo Fisher Scientific.
7.2.1 Thermo Fisher Scientific. Business Overview
7.2.2 Thermo Fisher Scientific. Respiratory Infectious Disease Diagnostics Quarterly Revenue, 2020
7.2.3 Thermo Fisher Scientific. Respiratory Infectious Disease Diagnostics Product Introduction
7.2.4 Thermo Fisher Scientific. Response to COVID-19 and Related Developments
7.3 Abbott
7.3.1 Abbott Business Overview
7.3.2 Abbott Respiratory Infectious Disease Diagnostics Quarterly Revenue, 2020
7.3.3 Abbott Respiratory Infectious Disease Diagnostics Product Introduction
7.3.4 Abbott Response to COVID-19 and Related Developments
7.4 Koninklijke Philips
7.4.1 Koninklijke Philips Business Overview
7.4.2 Koninklijke Philips Respiratory Infectious Disease Diagnostics Quarterly Revenue, 2020
7.4.3 Koninklijke Philips Respiratory Infectious Disease Diagnostics Product Introduction
7.4.4 Koninklijke Philips Response to COVID-19 and Related Developments
7.5 Cardinal Health
7.5.1 Cardinal Health Business Overview
7.5.2 Cardinal Health Respiratory Infectious Disease Diagnostics Quarterly Revenue, 2020
7.5.3 Cardinal Health Respiratory Infectious Disease Diagnostics Product Introduction
7.5.4 Cardinal Health Response to COVID-19 and Related Developments
7.6 COSMED
7.6.1 COSMED Business Overview
7.6.2 COSMED Respiratory Infectious Disease Diagnostics Quarterly Revenue, 2020
7.6.3 COSMED Respiratory Infectious Disease Diagnostics Product Introduction
7.6.4 COSMED Response to COVID-19 and Related Developments
7.7 Smiths Group
7.7.1 Smiths Group Business Overview
7.7.2 Smiths Group Respiratory Infectious Disease Diagnostics Quarterly Revenue, 2020
7.7.3 Smiths Group Respiratory Infectious Disease Diagnostics Product Introduction
7.7.4 Smiths Group Response to COVID-19 and Related Developments
7.8 NIHON KOHDEN CORPORATION
7.8.1 NIHON KOHDEN CORPORATION Business Overview
7.8.2 NIHON KOHDEN CORPORATION Respiratory Infectious Disease Diagnostics Quarterly Revenue, 2020
7.8.3 NIHON KOHDEN CORPORATION Respiratory Infectious Disease Diagnostics Product Introduction
7.8.4 NIHON KOHDEN CORPORATION Response to COVID-19 and Related Developments
7.9 Becton
7.9.1 Becton Business Overview
7.9.2 Becton Respiratory Infectious Disease Diagnostics Quarterly Revenue, 2020
7.9.3 Becton Respiratory Infectious Disease Diagnostics Product Introduction
7.9.4 Becton Response to COVID-19 and Related Developments
7.10 Dickinson
7.10.1 Dickinson Business Overview
7.10.2 Dickinson Respiratory Infectious Disease Diagnostics Quarterly Revenue, 2020
7.10.3 Dickinson Respiratory Infectious Disease Diagnostics Product Introduction
7.10.4 Dickinson Response to COVID-19 and Related Developments
7.11 F.Hoffmann
7.11.1 F.Hoffmann Business Overview
7.11.2 F.Hoffmann Respiratory Infectious Disease Diagnostics Quarterly Revenue, 2020
7.11.3 F.Hoffmann Respiratory Infectious Disease Diagnostics Product Introduction
7.11.4 F.Hoffmann Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Respiratory Infectious Disease Diagnostics Assessment
Table 9. COVID-19 Impact: Respiratory Infectious Disease Diagnostics Market Trends
Table 10. COVID-19 Impact Global Respiratory Infectious Disease Diagnostics Market Size
Table 11. Global Respiratory Infectious Disease Diagnostics Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Respiratory Infectious Disease Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Respiratory Infectious Disease Diagnostics Market Growth Drivers
Table 14. Global Respiratory Infectious Disease Diagnostics Market Restraints
Table 15. Global Respiratory Infectious Disease Diagnostics Market Opportunities
Table 16. Global Respiratory Infectious Disease Diagnostics Market Challenges
Table 17. By Players, Respiratory Infectious Disease Diagnostics Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Respiratory Infectious Disease Diagnostics Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Respiratory Infectious Disease Diagnostics Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Respiratory Infectious Disease Diagnostics Market
Table 21. Key Players Respiratory Infectious Disease Diagnostics Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Respiratory Infectious Disease Diagnostics Market Size 2019-2021, (US$ Million)
Table 24. Global Respiratory Infectious Disease Diagnostics Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Respiratory Infectious Disease Diagnostics Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 57. Abbott Laboratories Business Overview
Table 58. Abbott Laboratories Respiratory Infectious Disease Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Abbott Laboratories Respiratory Infectious Disease Diagnostics Product
Table 60. Abbott Laboratories Response to COVID-19 and Related Developments
Table 61. Thermo Fisher Scientific. Business Overview
Table 62. Thermo Fisher Scientific. Respiratory Infectious Disease Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Thermo Fisher Scientific. Respiratory Infectious Disease Diagnostics Product
Table 64. Thermo Fisher Scientific. Response to COVID-19 and Related Developments
Table 65. Abbott Business Overview
Table 66. Abbott Respiratory Infectious Disease Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Abbott Respiratory Infectious Disease Diagnostics Product
Table 68. Abbott Response to COVID-19 and Related Developments
Table 69. Koninklijke Philips Business Overview
Table 70. Koninklijke Philips Respiratory Infectious Disease Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Koninklijke Philips Respiratory Infectious Disease Diagnostics Product
Table 72. Koninklijke Philips Response to COVID-19 and Related Developments
Table 73. Cardinal Health Business Overview
Table 74. Cardinal Health Respiratory Infectious Disease Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Cardinal Health Respiratory Infectious Disease Diagnostics Product
Table 76. Cardinal Health Response to COVID-19 and Related Developments
Table 77. COSMED Business Overview
Table 78. COSMED Respiratory Infectious Disease Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. COSMED Respiratory Infectious Disease Diagnostics Product
Table 80. COSMED Response to COVID-19 and Related Developments
Table 81. Smiths Group Business Overview
Table 82. Smiths Group Respiratory Infectious Disease Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Smiths Group Respiratory Infectious Disease Diagnostics Product
Table 84. Smiths Group Response to COVID-19 and Related Developments
Table 85. NIHON KOHDEN CORPORATION Business Overview
Table 86. NIHON KOHDEN CORPORATION Respiratory Infectious Disease Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. NIHON KOHDEN CORPORATION Respiratory Infectious Disease Diagnostics Product
Table 88. NIHON KOHDEN CORPORATION Response to COVID-19 and Related Developments
Table 89. Becton Business Overview
Table 90. Becton Respiratory Infectious Disease Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Becton Respiratory Infectious Disease Diagnostics Product
Table 92. Becton Response to COVID-19 and Related Developments
Table 93. Dickinson Business Overview
Table 94. Dickinson Respiratory Infectious Disease Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Dickinson Respiratory Infectious Disease Diagnostics Product
Table 96. Dickinson Response to COVID-19 and Related Developments
Table 97. F.Hoffmann Business Overview
Table 98. F.Hoffmann Respiratory Infectious Disease Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. F.Hoffmann Respiratory Infectious Disease Diagnostics Product
Table 100. F.Hoffmann Response to COVID-19 and Related Developments
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Respiratory Infectious Disease Diagnostics Assessment
Table 9. COVID-19 Impact: Respiratory Infectious Disease Diagnostics Market Trends
Table 10. COVID-19 Impact Global Respiratory Infectious Disease Diagnostics Market Size
Table 11. Global Respiratory Infectious Disease Diagnostics Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Respiratory Infectious Disease Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Respiratory Infectious Disease Diagnostics Market Growth Drivers
Table 14. Global Respiratory Infectious Disease Diagnostics Market Restraints
Table 15. Global Respiratory Infectious Disease Diagnostics Market Opportunities
Table 16. Global Respiratory Infectious Disease Diagnostics Market Challenges
Table 17. By Players, Respiratory Infectious Disease Diagnostics Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Respiratory Infectious Disease Diagnostics Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Respiratory Infectious Disease Diagnostics Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Respiratory Infectious Disease Diagnostics Market
Table 21. Key Players Respiratory Infectious Disease Diagnostics Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Respiratory Infectious Disease Diagnostics Market Size 2019-2021, (US$ Million)
Table 24. Global Respiratory Infectious Disease Diagnostics Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Respiratory Infectious Disease Diagnostics Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Respiratory Infectious Disease Diagnostics Market Size, 2019-2021 (US$ Million)
Table 57. Abbott Laboratories Business Overview
Table 58. Abbott Laboratories Respiratory Infectious Disease Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Abbott Laboratories Respiratory Infectious Disease Diagnostics Product
Table 60. Abbott Laboratories Response to COVID-19 and Related Developments
Table 61. Thermo Fisher Scientific. Business Overview
Table 62. Thermo Fisher Scientific. Respiratory Infectious Disease Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Thermo Fisher Scientific. Respiratory Infectious Disease Diagnostics Product
Table 64. Thermo Fisher Scientific. Response to COVID-19 and Related Developments
Table 65. Abbott Business Overview
Table 66. Abbott Respiratory Infectious Disease Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Abbott Respiratory Infectious Disease Diagnostics Product
Table 68. Abbott Response to COVID-19 and Related Developments
Table 69. Koninklijke Philips Business Overview
Table 70. Koninklijke Philips Respiratory Infectious Disease Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Koninklijke Philips Respiratory Infectious Disease Diagnostics Product
Table 72. Koninklijke Philips Response to COVID-19 and Related Developments
Table 73. Cardinal Health Business Overview
Table 74. Cardinal Health Respiratory Infectious Disease Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Cardinal Health Respiratory Infectious Disease Diagnostics Product
Table 76. Cardinal Health Response to COVID-19 and Related Developments
Table 77. COSMED Business Overview
Table 78. COSMED Respiratory Infectious Disease Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. COSMED Respiratory Infectious Disease Diagnostics Product
Table 80. COSMED Response to COVID-19 and Related Developments
Table 81. Smiths Group Business Overview
Table 82. Smiths Group Respiratory Infectious Disease Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Smiths Group Respiratory Infectious Disease Diagnostics Product
Table 84. Smiths Group Response to COVID-19 and Related Developments
Table 85. NIHON KOHDEN CORPORATION Business Overview
Table 86. NIHON KOHDEN CORPORATION Respiratory Infectious Disease Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. NIHON KOHDEN CORPORATION Respiratory Infectious Disease Diagnostics Product
Table 88. NIHON KOHDEN CORPORATION Response to COVID-19 and Related Developments
Table 89. Becton Business Overview
Table 90. Becton Respiratory Infectious Disease Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Becton Respiratory Infectious Disease Diagnostics Product
Table 92. Becton Response to COVID-19 and Related Developments
Table 93. Dickinson Business Overview
Table 94. Dickinson Respiratory Infectious Disease Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Dickinson Respiratory Infectious Disease Diagnostics Product
Table 96. Dickinson Response to COVID-19 and Related Developments
Table 97. F.Hoffmann Business Overview
Table 98. F.Hoffmann Respiratory Infectious Disease Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. F.Hoffmann Respiratory Infectious Disease Diagnostics Product
Table 100. F.Hoffmann Response to COVID-19 and Related Developments
LIST OF FIGURES
Figure 1. Respiratory Infectious Disease Diagnostics Product Picture
Figure 2. Respiratory Infectious Disease Diagnostics Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Respiratory Infectious Disease Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Respiratory Infectious Disease Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Respiratory Infectious Disease Diagnostics Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Respiratory Infectious Disease Diagnostics Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Respiratory Infectious Disease Diagnostics Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Respiratory Infectious Disease Diagnostics Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Respiratory Infectious Disease Diagnostics Market Size Market Share, 2019-2021
Figure 1. Respiratory Infectious Disease Diagnostics Product Picture
Figure 2. Respiratory Infectious Disease Diagnostics Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Respiratory Infectious Disease Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Respiratory Infectious Disease Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Respiratory Infectious Disease Diagnostics Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Respiratory Infectious Disease Diagnostics Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Respiratory Infectious Disease Diagnostics Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Respiratory Infectious Disease Diagnostics Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Respiratory Infectious Disease Diagnostics Market Size Market Share, 2019-2021
